Bank of New York Mellon’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Buy |
|
|||||
|
2025
Q1 | $1.84M | Buy |
|
|||||
|
2024
Q4 | $2.41M | Sell |
|
|||||
|
2024
Q3 | $3.08M | Sell |
|
|||||
|
2024
Q2 | $2.77M | Buy |
|
|||||
|
2024
Q1 | $229K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $10.5K | Hold |
|
|||||
|
2023
Q1 | $6.74K | Hold |
|
|||||
|
2022
Q4 | $10.5K | Hold |
|
|||||
|
2022
Q3 | $12K | Sell |
|
|||||
|
2022
Q2 | $13K | Sell |
|
|||||
|
2022
Q1 | $362K | Sell |
|
|||||
|
2021
Q4 | $757K | Sell |
|
|||||
|
2021
Q3 | $1.27M | Buy |
|
|||||
|
2021
Q2 | $1.03M | Buy |
|
|||||
|
2021
Q1 | $1.14M | Sell |
|
|||||
|
2020
Q4 | $1.19M | Sell |
|
|||||
|
2020
Q3 | $1.07M | Buy |
|
|||||
|
2020
Q2 | $1.3M | Buy |
|
|||||
|
2020
Q1 | $443K | Buy |
|
|||||
|
2019
Q4 | $691K | Buy |
|
|||||
|
2019
Q3 | $690K | Sell |
|
|||||
|
2019
Q2 | $654K | Buy |
|
|||||
|
2019
Q1 | $495K | Buy |
|
|||||
|
2018
Q4 | $371K | Buy |
|
|||||
|
2018
Q3 | $424K | Buy |
|
|||||
|
2018
Q2 | $438K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $72K | Hold |
|
|||||
|
2017
Q3 | $65K | Hold |
|
|||||
|
2017
Q2 | $51K | Sell |
|
|||||
|
2017
Q1 | $157K | Buy |
|